NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/13/2025
Back to search
Official data from USPTO
EIKONIZO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EIKONIZO THERAPEUTICS
ST13
US500000090981385Class
42, 44
Filing
90981385
Registration
7789891
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/13/2025
Trademark type
Word
Nice classes
42, 44
Filing date
06/01/2021
Registration date
05/13/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2025
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2017-05-00
First use in commerce
2017-05-00
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
FALK,JONATHAN ROBERT
Law office
L40
Holders and representatives
Holders
Eikonizo Therapeutics, Inc.
Representatives
CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of drug discoveryimaging agentsbiotechnology and pharmaceuticals
Class 44
Providing a website featuring information in the field of treatment for medical conditions
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/13/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/24/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/24/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
04/24/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/17/2025
DRRR
DIVISIONAL REQUEST RECEIVED
01/09/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/09/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2024
PUBO
PUBLISHED FOR OPPOSITION
05/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2024
EXPT
EXPARTE APPEAL TERMINATED
04/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/26/2023
EXPI
EX PARTE APPEAL-INSTITUTED
04/26/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/26/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/26/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/26/2022
GNFR
FINAL REFUSAL E-MAILED
10/26/2022
CNFR
FINAL REFUSAL WRITTEN
10/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2022
ALIE
ASSIGNED TO LIE
10/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/25/2022
GNRT
NON-FINAL ACTION E-MAILED
02/25/2022
CNRT
NON-FINAL ACTION WRITTEN
02/25/2022
DOCK
ASSIGNED TO EXAMINER
02/15/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/25/2021
Continuous trademark protection
Get notified about every new filing that threatens EIKONIZO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.